UBS and JPMorgan Slash Lennar Targets as Housing Demand Cools
UBS and JPMorgan slash Lennar price targets after weaker Q3 guidance and softening housing demand. What it means for LEN stock and homebuilder investors.
Markets
Read More
RBC Just Initiated Coverage of GE HealthCare. Here’s Why It Matters.
RBC Capital initiates coverage of GE HealthCare Technologies with an Outperform rating and $98 target. Here’s what drives the bullish case in med-tech and AI diagnostics.
Why Verizon, AT&T, and T-Mobile Should Fear Elon Musk’s Next Move
Elon Musk’s Starlink direct-to-cell service threatens to upend the $300B telecom industry. Verizon, AT&T, and T-Mobile face a reckoning as satellite bypasses towers.
Is NVDA Still a Billionaire Favorite? The Numbers Say Yes – With a Twist
Is NVIDIA still a top semiconductor stock pick for billionaires? Analysis of Q1 2024 13F filings, valuation, risks, and alternative AI plays.
Netflix Fraudster Carl Rinsch Gets 30 Months: The $11 Million Sci-Fi Scam That Blew Up
Carl Rinsch, the director who defrauded Netflix of $11 million for a sci-fi series, was sentenced to 30 months in prison. Inside the scam and what it means for streaming investors.
Former Chinese Billionaire and Bannon Associate Sentenced for Massive Fraud
Former Chinese billionaire Miles Guo, a Steve Bannon associate, sentenced to 18 years for $1 billion fraud. He used anti-communist pitch to fund Bugattis and mansions.
India’s Biggest Share Sales Tell the Story of a Nation Glued to Its Phones
India’s biggest share sales—NSE’s IPO and Jio Platforms’ fundraising—reveal a nation transformed by smartphones. How mobile-first consumption drives markets, and what it means for investors.
2.5 Years for Fraud: Hollywood Director Blew Netflix Cash on Ferraris
Hollywood director Carl Erik Rinsch sentenced to 2.5 years for defrauding Netflix of $11 million, spending money on Ferraris, Rolls-Royces, and crypto instead of making a sci-fi series.
Chinese Tycoon Guo Wengui Gets 30 Years in US Fraud Case
Chinese billionaire Guo Wengui sentenced to 30 years in US federal prison for defrauding 200,000+ followers in a $1 billion Ponzi scheme. The story behind the fraud.
Natera Stock Hits Record High on New Colon Cancer Test Coverage
Natera stock hits an all-time high after Medicare expands coverage for its Signatera colon cancer test. We break down what this means for patients, investors, and the future of liquid biopsy.
Top 5 Container Lines Bet Big on Europe’s Terminals: What It Means
The top 5 container lines are spending billions on European terminals. Discover the strategy behind their land grab and what it means for trade, shipping costs, and investors.
Figma (FIG): The Best Stock to Buy Right Now (Not SpaceX)
Figma (FIG) just IPOd at $35 with 67% revenue growth. Forget SpaceX — this design software stock is a better buy for retail investors. Analysis, risks, and entry strategy inside.